BOLT Bolt Biotherapeutics, Inc.: institutional ownership and insider trading
24 funds reported holding $2.36M of Bolt Biotherapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $64.4K, with 2 new positions and 3 funds selling out; over the last 12 months insiders bought $5.60K and sold $128K on the open market.
Famous investors holding BOLT
- Renaissance Technologies (Renaissance Technologies): $380K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $219K, 0.0% of the portfolio
Largest institutional holders of BOLT
- Sofinnova Investments, Inc. — $530K
- RENAISSANCE TECHNOLOGIES LLC — $380K
- Vivo Capital, LLC — $279K
- CITADEL ADVISORS LLC — $219K
- T3 Companies, LLC — $140K
- Board of Trustees of The Leland Stanford Junior University — $139K
- PFIZER INC (PFE) — $134K
- Lynx1 Capital Management LP — $119K
- NANO CAP NEW MILLENNIUM GROWTH FUND L P — $106K
- GEODE CAPITAL MANAGEMENT, LLC — $73.6K
Recent BOLT insider trades
- Sep 18, 2026: Quinn William P. sold 17,566 shares ($58.4K)
- Sep 18, 2026: Nemec Sarah sold 7,842 shares ($26.1K)
- Sep 18, 2026: Yonehiro Grant sold 13,176 shares ($43.8K)
- Jun 5, 2026: Quinn William P. bought 637 shares ($2.47K)
5%+ owners
- Renaissance Technologies LLC: 5.1% (Schedule 13G, filed Aug 13, 2026)